Variant report
Variant | rs7833129 |
---|---|
Chromosome Location | chr8:104516040-104516041 |
allele | A/G |
Outlinks | Ensembl   UCSC |
- TF binding region (count:1)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:1 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | STAT3 | chr8:104515870-104516252 | MCF10A-Er-Src | breast: | n/a | chr8:104516205-104516212 chr8:104515977-104515985 |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:104514967..104517369-chr8:104518518..104520384,2 | K562 | blood: | |
2 | chr8:104510408..104513975-chr8:104514318..104516305,3 | MCF-7 | breast: | |
3 | chr8:104515296..104517428-chr8:104521328..104523419,2 | MCF-7 | breast: | |
4 | chr8:104514386..104518041-chr8:104521467..104524812,4 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000253477 | TF binding region |
ENSG00000253477 | Chromatin interaction |
ENSG00000176406 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs10046611 | 0.82[AFR][1000 genomes];1.00[AMR][1000 genomes] |
rs10086572 | 0.89[AFR][1000 genomes] |
rs10086723 | 0.84[AFR][1000 genomes] |
rs10086733 | 1.00[YRI][hapmap];0.89[AFR][1000 genomes] |
rs10087778 | 0.86[AFR][1000 genomes];1.00[AMR][1000 genomes] |
rs10089162 | 0.90[AFR][1000 genomes] |
rs10089301 | 0.90[AFR][1000 genomes] |
rs10089491 | 0.90[AFR][1000 genomes] |
rs10090897 | 0.86[AFR][1000 genomes];1.00[AMR][1000 genomes] |
rs10091058 | 1.00[AMR][1000 genomes] |
rs10093711 | 0.88[AFR][1000 genomes] |
rs10093848 | 0.89[AFR][1000 genomes] |
rs10094153 | 0.89[AFR][1000 genomes] |
rs10095409 | 0.88[AFR][1000 genomes] |
rs10096428 | 0.82[AFR][1000 genomes] |
rs10097744 | 0.83[AFR][1000 genomes] |
rs10098555 | 0.88[AFR][1000 genomes] |
rs10098692 | 0.88[AFR][1000 genomes] |
rs10098860 | 0.82[AFR][1000 genomes];1.00[AMR][1000 genomes] |
rs10099408 | 0.88[AFR][1000 genomes] |
rs10101805 | 0.87[AFR][1000 genomes] |
rs10102124 | 0.89[AFR][1000 genomes] |
rs10102523 | 1.00[YRI][hapmap];0.89[AFR][1000 genomes] |
rs10103311 | 0.90[AFR][1000 genomes] |
rs10104009 | 0.90[AFR][1000 genomes] |
rs10106319 | 0.96[AFR][1000 genomes];1.00[AMR][1000 genomes] |
rs10107074 | 0.90[AFR][1000 genomes] |
rs10110202 | 0.88[AFR][1000 genomes] |
rs10112996 | 0.89[AFR][1000 genomes] |
rs1024875 | 0.81[AFR][1000 genomes] |
rs10505043 | 1.00[YRI][hapmap];0.87[AFR][1000 genomes] |
rs10505044 | 0.90[AFR][1000 genomes] |
rs10505045 | 0.89[AFR][1000 genomes] |
rs10505046 | 1.00[YRI][hapmap];0.89[AFR][1000 genomes] |
rs10955322 | 0.82[AFR][1000 genomes] |
rs11775389 | 0.86[AFR][1000 genomes] |
rs11776535 | 0.86[AFR][1000 genomes] |
rs11776670 | 0.90[AFR][1000 genomes] |
rs11785029 | 0.88[AFR][1000 genomes] |
rs11785034 | 0.88[AFR][1000 genomes] |
rs11785081 | 0.84[AFR][1000 genomes] |
rs11785526 | 0.88[AFR][1000 genomes] |
rs11786899 | 0.83[AFR][1000 genomes] |
rs12707787 | 0.82[AFR][1000 genomes] |
rs13248598 | 0.87[AFR][1000 genomes] |
rs13249922 | 0.89[AFR][1000 genomes] |
rs13257065 | 0.86[AFR][1000 genomes] |
rs13257474 | 1.00[YRI][hapmap];0.92[AFR][1000 genomes] |
rs13257551 | 0.87[AFR][1000 genomes] |
rs13261470 | 0.90[AFR][1000 genomes] |
rs13265161 | 0.84[AFR][1000 genomes] |
rs13268468 | 0.90[AFR][1000 genomes] |
rs13269260 | 0.82[AFR][1000 genomes] |
rs13272442 | 0.89[AFR][1000 genomes] |
rs13274173 | 0.84[AFR][1000 genomes] |
rs13276817 | 0.90[AFR][1000 genomes] |
rs13277802 | 0.88[AFR][1000 genomes] |
rs13278213 | 0.84[AFR][1000 genomes] |
rs13282559 | 0.84[AFR][1000 genomes] |
rs13439010 | 0.82[AFR][1000 genomes] |
rs13439015 | 0.82[AFR][1000 genomes] |
rs13439017 | 0.82[AFR][1000 genomes] |
rs13439770 | 0.96[YRI][hapmap];1.00[AMR][1000 genomes] |
rs1436596 | 0.87[AFR][1000 genomes];1.00[AMR][1000 genomes] |
rs1436603 | 0.89[AFR][1000 genomes] |
rs1582767 | 0.84[AFR][1000 genomes] |
rs1582770 | 0.86[AFR][1000 genomes] |
rs16870445 | 0.90[AFR][1000 genomes] |
rs16870446 | 0.90[AFR][1000 genomes] |
rs16870450 | 0.86[AFR][1000 genomes];1.00[AMR][1000 genomes] |
rs16870502 | 0.82[AFR][1000 genomes] |
rs16870588 | 0.84[AFR][1000 genomes] |
rs16870614 | 0.96[YRI][hapmap] |
rs16870616 | 0.96[YRI][hapmap] |
rs17234389 | 0.96[YRI][hapmap] |
rs1820445 | 0.86[AFR][1000 genomes] |
rs1946370 | 0.88[AFR][1000 genomes] |
rs2160715 | 0.88[AFR][1000 genomes] |
rs28435392 | 0.84[AFR][1000 genomes];1.00[AMR][1000 genomes] |
rs28470319 | 0.89[AFR][1000 genomes] |
rs28480679 | 0.93[AFR][1000 genomes];1.00[AMR][1000 genomes] |
rs28482300 | 0.84[AFR][1000 genomes] |
rs28494061 | 0.84[AFR][1000 genomes] |
rs28502010 | 0.86[AFR][1000 genomes] |
rs28563855 | 0.89[AFR][1000 genomes] |
rs28567610 | 0.90[AFR][1000 genomes] |
rs28608939 | 0.89[AFR][1000 genomes];1.00[AMR][1000 genomes] |
rs28626315 | 0.87[AFR][1000 genomes] |
rs28751033 | 0.86[AFR][1000 genomes];1.00[AMR][1000 genomes] |
rs28754823 | 0.89[AFR][1000 genomes] |
rs28790017 | 0.88[AFR][1000 genomes] |
rs28799635 | 0.82[AFR][1000 genomes] |
rs28862332 | 0.86[AFR][1000 genomes] |
rs28869329 | 0.89[AFR][1000 genomes] |
rs34333071 | 0.82[AFR][1000 genomes] |
rs34344264 | 0.90[AFR][1000 genomes] |
rs34478067 | 0.85[AFR][1000 genomes] |
rs34579655 | 0.89[AFR][1000 genomes] |
rs34651893 | 0.90[AFR][1000 genomes] |
rs34840668 | 0.82[AFR][1000 genomes] |
rs34883289 | 0.90[AFR][1000 genomes] |
rs35052041 | 0.82[AFR][1000 genomes] |
rs35177572 | 0.90[AFR][1000 genomes] |
rs35196143 | 0.84[AFR][1000 genomes] |
rs4299973 | 0.84[AFR][1000 genomes] |
rs4310171 | 0.85[AFR][1000 genomes] |
rs4431562 | 0.86[AFR][1000 genomes] |
rs4520130 | 0.83[AFR][1000 genomes] |
rs4642610 | 0.90[AFR][1000 genomes] |
rs4642611 | 0.90[AFR][1000 genomes] |
rs57621488 | 0.86[AFR][1000 genomes];1.00[AMR][1000 genomes] |
rs57915677 | 1.00[AMR][1000 genomes] |
rs58052023 | 0.82[AFR][1000 genomes];1.00[AMR][1000 genomes] |
rs58850105 | 0.96[AFR][1000 genomes];1.00[AMR][1000 genomes] |
rs6468881 | 0.86[AFR][1000 genomes] |
rs6468882 | 0.86[AFR][1000 genomes] |
rs66767358 | 0.89[AFR][1000 genomes] |
rs66873473 | 0.89[AFR][1000 genomes] |
rs67217645 | 0.88[AFR][1000 genomes] |
rs68145832 | 0.89[AFR][1000 genomes] |
rs6983590 | 0.84[AFR][1000 genomes] |
rs6985202 | 0.89[AFR][1000 genomes] |
rs6985351 | 0.96[YRI][hapmap] |
rs6986085 | 1.00[YRI][hapmap];0.90[AFR][1000 genomes] |
rs6986283 | 0.96[YRI][hapmap] |
rs6986935 | 0.84[AFR][1000 genomes] |
rs6987023 | 0.87[AFR][1000 genomes] |
rs6987885 | 0.84[AFR][1000 genomes] |
rs6990927 | 0.86[AFR][1000 genomes] |
rs6991393 | 0.86[AFR][1000 genomes] |
rs6995271 | 0.88[YRI][hapmap];0.86[AFR][1000 genomes];1.00[AMR][1000 genomes] |
rs6995914 | 0.87[AFR][1000 genomes];1.00[AMR][1000 genomes] |
rs6996896 | 0.90[AFR][1000 genomes] |
rs7000557 | 1.00[AMR][1000 genomes] |
rs7000677 | 0.88[AFR][1000 genomes];1.00[AMR][1000 genomes] |
rs7001794 | 0.90[AFR][1000 genomes] |
rs7002538 | 0.83[AFR][1000 genomes] |
rs7002805 | 0.84[AFR][1000 genomes] |
rs7002996 | 0.89[AFR][1000 genomes] |
rs7003098 | 0.80[AFR][1000 genomes] |
rs7004369 | 0.85[AFR][1000 genomes] |
rs7004568 | 0.86[AFR][1000 genomes] |
rs7005300 | 0.87[AFR][1000 genomes];1.00[AMR][1000 genomes] |
rs7016210 | 0.84[AFR][1000 genomes] |
rs7341681 | 0.96[AFR][1000 genomes];1.00[AMR][1000 genomes] |
rs7341682 | 0.96[AFR][1000 genomes];1.00[AMR][1000 genomes] |
rs73700414 | 0.82[AFR][1000 genomes];1.00[AMR][1000 genomes] |
rs73700421 | 0.87[AFR][1000 genomes];1.00[AMR][1000 genomes] |
rs73701884 | 0.84[AFR][1000 genomes] |
rs7813100 | 0.89[AFR][1000 genomes] |
rs7817840 | 0.84[AFR][1000 genomes] |
rs7817973 | 0.81[AFR][1000 genomes] |
rs7818492 | 0.86[AFR][1000 genomes] |
rs7820965 | 0.86[AFR][1000 genomes] |
rs7822390 | 0.83[AFR][1000 genomes] |
rs7823940 | 0.84[AFR][1000 genomes] |
rs7824747 | 0.81[AFR][1000 genomes] |
rs7825184 | 0.86[AFR][1000 genomes] |
rs7825842 | 0.92[AFR][1000 genomes] |
rs7826021 | 0.82[AFR][1000 genomes] |
rs7827973 | 0.89[AFR][1000 genomes] |
rs7829735 | 0.87[AFR][1000 genomes] |
rs7830158 | 0.89[AFR][1000 genomes] |
rs7835792 | 0.90[AFR][1000 genomes] |
rs7836022 | 0.89[AFR][1000 genomes] |
rs7836148 | 0.86[AFR][1000 genomes];1.00[AMR][1000 genomes] |
rs7838105 | 0.84[AFR][1000 genomes] |
rs7839383 | 0.86[AFR][1000 genomes] |
rs7841668 | 0.84[AFR][1000 genomes] |
rs7842148 | 0.96[AFR][1000 genomes];1.00[AMR][1000 genomes] |
rs7842972 | 1.00[YRI][hapmap];0.96[AFR][1000 genomes];1.00[AMR][1000 genomes] |
rs7843598 | 0.94[AFR][1000 genomes];1.00[AMR][1000 genomes] |
rs7845290 | 1.00[YRI][hapmap];0.89[AFR][1000 genomes] |
rs7845384 | 0.81[AFR][1000 genomes];0.85[AMR][1000 genomes] |
rs9297332 | 1.00[YRI][hapmap];0.85[AFR][1000 genomes];1.00[AMR][1000 genomes] |
rs9297333 | 1.00[YRI][hapmap];0.92[AFR][1000 genomes] |
rs9297334 | 1.00[YRI][hapmap];0.89[AFR][1000 genomes] |
rs9297335 | 1.00[YRI][hapmap];0.89[AFR][1000 genomes] |
rs9771560 | 1.00[AMR][1000 genomes] |
rs9772647 | 0.84[AFR][1000 genomes] |
rs9772699 | 0.84[AFR][1000 genomes] |
rs9774228 | 0.84[AFR][1000 genomes] |
rs9987225 | 0.89[AFR][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv429931 | chr8:104097396-104878014 | Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Transcr. at gene 5' and 3' Strong transcription Flanking Active TSS ZNF genes & repeats Active TSS Bivalent/Poised TSS Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 82 gene(s) | inside rSNPs | diseases |
2 | nsv1020476 | chr8:104312212-104924482 | Genic enhancers Enhancers Flanking Active TSS Active TSS Weak transcription Bivalent/Poised TSS Strong transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 42 gene(s) | inside rSNPs | diseases |
3 | nsv539704 | chr8:104312212-104924482 | Flanking Bivalent TSS/Enh Enhancers ZNF genes & repeats Weak transcription Active TSS Strong transcription Flanking Active TSS Genic enhancers Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 42 gene(s) | inside rSNPs | diseases |
4 | nsv1023048 | chr8:104355188-104872701 | Flanking Active TSS Strong transcription Weak transcription Active TSS Enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Genic enhancers Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 39 gene(s) | inside rSNPs | diseases |
5 | nsv539705 | chr8:104355188-104872701 | ZNF genes & repeats Enhancers Strong transcription Bivalent/Poised TSS Weak transcription Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 39 gene(s) | inside rSNPs | diseases |
6 | nsv1021345 | chr8:104361854-104879684 | Enhancers Active TSS Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Strong transcription ZNF genes & repeats Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 39 gene(s) | inside rSNPs | diseases |
7 | nsv1032085 | chr8:104362187-104878345 | Active TSS Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Strong transcription Bivalent/Poised TSS ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 39 gene(s) | inside rSNPs | diseases |
8 | nsv1034183 | chr8:104369940-104814008 | Weak transcription Strong transcription Enhancers Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 38 gene(s) | inside rSNPs | diseases |
9 | nsv539707 | chr8:104369940-104814008 | Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Strong transcription Genic enhancers Active TSS Bivalent/Poised TSS Enhancers ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 38 gene(s) | inside rSNPs | diseases |
10 | esv2753239 | chr8:104404824-104545824 | Weak transcription Bivalent Enhancer Enhancers Strong transcription Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS ZNF genes & repeats Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 31 gene(s) | inside rSNPs | diseases |
No data |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:104514200-104519000 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
2 | chr8:104514200-104524000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
3 | chr8:104514800-104518800 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
4 | chr8:104515200-104516800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
5 | chr8:104515200-104519000 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
6 | chr8:104515200-104522200 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
7 | chr8:104515400-104516200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr8:104515600-104518600 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
9 | chr8:104515800-104516200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
10 | chr8:104516000-104516200 | Flanking Active TSS | HUES48 Cell Line | embryonic stem cell |
11 | chr8:104516000-104518200 | Enhancers | Pancreatic Islets | Pancreatic Islet |
12 | chr8:104516000-104522200 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |